<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Genscript Biotech Corporation — News on 6ix</title>
<link>https://6ix.com/company/genscript-biotech-corp</link>
<description>Latest news and press releases for Genscript Biotech Corporation on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/genscript-biotech-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683686e578dffbe2df16aa9a.webp</url>
<title>Genscript Biotech Corporation</title>
<link>https://6ix.com/company/genscript-biotech-corp</link>
</image>
<item>
<title>GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-sets-new-benchmark-for-responsible-biotech-leadership-with-2025-esg-report</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-sets-new-benchmark-for-responsible-biotech-leadership-with-2025-esg-report</guid>
<pubDate>Tue, 14 Apr 2026 12:00:00 GMT</pubDate>
<description>GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the company at the forefront of responsible innovation in biotechnology and reinforcing its role as a trusted global partner powering the future of healthcare, science, and sustainability.</description>
</item>
<item>
<title>GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-and-mimulus-partner-to-industrialize-dna-based-data-storage-for-the-ai-era</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-and-mimulus-partner-to-industrialize-dna-based-data-storage-for-the-ai-era</guid>
<pubDate>Thu, 09 Apr 2026 12:00:00 GMT</pubDate>
<description>GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in Molecular Archive Technology™, today announced a strategic collaboration to industrialize DNA-based data storage, a technology poised to transform how the world preserves data in the age of Artificial Intelligence.</description>
</item>
<item>
<title>GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-corp-reports-strong-fy2025-results-as-integrated-platform-strategy-and-global-execution-drive-high-quality-growth</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-corp-reports-strong-fy2025-results-as-integrated-platform-strategy-and-global-execution-drive-high-quality-growth</guid>
<pubDate>Mon, 16 Mar 2026 10:54:00 GMT</pubDate>
<description>GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth</description>
</item>
<item>
<title>GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San Francisco</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-global-forum-scripting-130100049</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-global-forum-scripting-130100049</guid>
<pubDate>Thu, 29 Jan 2026 13:01:00 GMT</pubDate>
<description>GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully concluded the 2026 GenScript Biotech Global Forum on January 14 in San Francisco during the annual J.P. Morgan Healthcare Conference. Held under the theme "Scripting Possibilities – The Future of Therapeutic Innovation," the Forum convened close to 1,000 international attendees. The Forum explored how artificial intelligence is reshaping discovery and what it will take to scale innovation</description>
</item>
<item>
<title>GenScript is Scripting Possibilities in AI-Driven Drug Discovery as Wet-Lab Partner for Latent-X2 Innovation</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-is-scripting-possibilities-in-ai-driven-drug-discovery-as-wet-lab-partner-for-latent-x2-innovation</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-is-scripting-possibilities-in-ai-driven-drug-discovery-as-wet-lab-partner-for-latent-x2-innovation</guid>
<pubDate>Wed, 28 Jan 2026 14:00:00 GMT</pubDate>
<description>GenScript Biotech Corporation, a global leader in life science research and biotech solutions, today announced its supporting role in the experimental validation of Latent-X2 — further proving that GenScript is Scripting Possibilities in AI-driven drug discovery. Latent-X2 is the next-generation AI model developed by Latent Labs to design antibodies and peptides with drug-like properties from the first design cycle.</description>
</item>
<item>
<title>'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/scripting-possibilities-in-biotechnology-global-innovators-converge-in-san-francisco-for-genscripts-5th-annual-biotech-forum-during-jpm-week</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/scripting-possibilities-in-biotechnology-global-innovators-converge-in-san-francisco-for-genscripts-5th-annual-biotech-forum-during-jpm-week</guid>
<pubDate>Tue, 06 Jan 2026 13:30:00 GMT</pubDate>
<description>GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San Francisco Marriott Marquis, with both in-person and virtual attendance options available.</description>
</item>
<item>
<title>Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/exploring-the-next-era-of-cgt-and-unlocking-limitless-possibilities-the-genscript-biotech-global-forum-london-2025-wraps-up</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/exploring-the-next-era-of-cgt-and-unlocking-limitless-possibilities-the-genscript-biotech-global-forum-london-2025-wraps-up</guid>
<pubDate>Sat, 22 Nov 2025 12:28:00 GMT</pubDate>
<description>GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum London 2025 in the UK. This marks the Forum's second edition in Europe and the eighth consecutive Global Industry Forum organized by GenScript since its debut at the 2020 J.P. Morgan Healthcare Conference in San Francisco—highlighting the Forum's continued role in supporting industry exchange and advancing the development of the Cell & Gene Therap</description>
</item>
<item>
<title>GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-demonstrates-profitable-scale-and-strategic-leadership-in-h1-2025-establishing-clear-industry-leadership-through-accelerated-growth-and-innovation</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-demonstrates-profitable-scale-and-strategic-leadership-in-h1-2025-establishing-clear-industry-leadership-through-accelerated-growth-and-innovation</guid>
<pubDate>Sun, 17 Aug 2025 12:01:00 GMT</pubDate>
<description>GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 2025, underscoring its ability to deliver profitable growth at scale through strategic globalization, differentiated technology, and relentless innovation.</description>
</item>
<item>
<title>GenScript Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-unveils-new-global-identity-scripting-possibilities-to-power-the-future-of-biotechnology</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-unveils-new-global-identity-scripting-possibilities-to-power-the-future-of-biotechnology</guid>
<pubDate>Fri, 08 Aug 2025 12:30:00 GMT</pubDate>
<description>GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting Possibilities—a future-forward identity designed to match the speed, complexity, and promise of modern biotechnology.</description>
</item>
<item>
<title>GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-biotechs-msci-esg-rating-upgraded-to-aa-recognized-as-a-global-leader</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-biotechs-msci-esg-rating-upgraded-to-aa-recognized-as-a-global-leader</guid>
<pubDate>Fri, 01 Aug 2025 02:02:00 GMT</pubDate>
<description>GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that its ESG rating has been upgraded to AA from A by MSCI in recognition of the company's excellence in the areas of product safety & quality and human capital development, as well as continuous improvement in environment and governance practices.</description>
</item>
<item>
<title>GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-earns-ecovadis-silver-medal-ranking-in-top-15percent-globally-for-sustainability</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-earns-ecovadis-silver-medal-ranking-in-top-15percent-globally-for-sustainability</guid>
<pubDate>Wed, 09 Jul 2025 12:32:00 GMT</pubDate>
<description>GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that it has been awarded a Silver Medal by EcoVadis, a globally recognized business sustainability assessment platform. This recognition underscores its significant progress in the areas of environment, labor and human rights, ethics, and sustainable procurement. This silver medal places GenScript in the top 15% of all companies assessed by EcoVadis worldwide.</description>
</item>
<item>
<title>ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/probio-opens-flagship-us-plasmid-and-viral-vector-manufacturing-facility-in-hopewell-new-jersey-to-advance-cell-and-gene-therapy</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/probio-opens-flagship-us-plasmid-and-viral-vector-manufacturing-facility-in-hopewell-new-jersey-to-advance-cell-and-gene-therapy</guid>
<pubDate>Fri, 27 Jun 2025 10:30:00 GMT</pubDate>
<description>ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell, New Jersey. The 128,000 sq ft GMP facility is purpose-built for manufacturing high-quality plasmid DNA and viral vectors, including adeno-associated virus (AAV) and lentiviral vector (LVV) platforms, reflecting ProBio's dedication to acceleratin</description>
</item>
<item>
<title>GenScript Biotech Corporation Reports FY 2024 Results</title>
<link>https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-corporation-reports-fy-2024-results</link>
<guid isPermaLink="true">https://6ix.com/company/genscript-biotech-corp/news/genscript-biotech-corporation-reports-fy-2024-results</guid>
<pubDate>Wed, 12 Mar 2025 06:40:00 GMT</pubDate>
<description>GenScript Biotech Corporation (HKEX: 1548.HK), a leading global technology and service provider of life science R&D and manufacturing reported its financial results for the full year ended on December 31, 2024.</description>
</item>
</channel>
</rss>